Interesting Articles

Ageing and Parkinson’s disease: Why is advancing age the biggest risk factor?

The cost of forgetting: Dementia’s tax on financial health

Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease – A Randomized Clinical Trial